AzTrials
AzTrials

PainNCT01775371

Effectiveness and Feasibility of Patient Controlled Analgesia in the ED

A study of Pain, run by Albert Einstein College of Medicine at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Inadequate pain management is common in the Emergency Department (ED). Optimal treatment of pain necessitates titration to effective dose due to the large inter-individual variability in opioid requirement. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Pain
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
636 participants
Where
3 sitesUnited States
Study dates
Apr 2013to Feb 2016
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 to 65
  • Patient deemed by the ED attending physician to require IV opioid analgesia for pain and for whom the ED Attending Physician would consider using PCA

Who cannot join

  • Patients requiring initial resuscitation that would preclude the use of PCA
  • Long-term use of prescription or non-prescription opioids now or within the past year
  • Recent opioid use within the past 24 hours
  • Chronic pain syndromes
  • Clinician suspicion of current or past opioid dependence/abuse
  • Altered mental status/Clinical suspicion of intoxication
Show all 15Show fewer
  • Patients expected to require conscious sedation while in the ED
  • Pregnancy or breast-feeding
  • History of chronic obstructive pulmonary disease, history of sleep apnea syndrome, baseline oxygen saturation (room air) < 97%
  • Systolic blood pressure < 100 mm Hg
  • Use of sedative medications e.g. benzodiazepines, monoamine oxidase inhibitors, phenothiazines, or tricyclic antidepressants.
  • History of renal insufficiency/renal failure
  • Prior allergic reaction to morphine
  • Inability to provide informed consent or inability to understand or operate PCA device
  • Previous entry of patient into study

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

  • Jacobi Medical Center

    The Bronx, New York, 10461

  • Montefiore Medical Center - Moses Division

    The Bronx, New York, 10467

Other trials in United States

About this study

Background: Inadequate pain management is common in the Emergency Department (ED). Optimal treatment of pain necessitates titration to effective dose due to the large inter-individual variability in opioid requirement. However nurse administered titration is difficult to provide in this setting due to high patient to nurse and physician ratios and multiple urgent competing patient demands. Patient controlled analgesia (PCA) lets ED patients actively participate in pain management by allowing self-titration to their desired level of pain relief. A tightly controlled randomized clinical trial (RCT) funded by the National Institute of Nursing Research (NINR) recently completed by the investigators group provides promising preliminary support for the efficacy and safety of PCA for patients with abdominal pain at a single ED with a dedicated research nurse and standard loading dose given to all patients. Objective: The overall objective is to provide optimal pain management in the ED. Specific aims: 1)To compare the effectiveness and safety of PCA and non-PCA opioid analgesia when nurses involved in clinical care deliver the intervention to a broad group of ED patients with acute pain at multiple clinical centers. The primary hypothesis is that there will be a greater decline in pain over time and similar safety in patients randomized to receive PCA compared to patients receiving standard opioid analgesia. 2) To describe the feasibility of PCA in terms of patient and provider acceptance, resource utilization and cost associated with PCA. Innovation: PCA represents a novel shift from the current provider-driven model of ED pain management to one in which the patient is an active participant. Few prior studies have evaluated ED PCA and no systematic evaluation of time and resources exists. Methodology: An RCT will be performed at 3 clinical centers. 750 patients with acute pain warranting IV opioid administration will be randomized to receive usual opioid analgesia determined by the provider or PCA (loading dose 0.1 mg/kg morphine and demand dose of 1 mg morphine available every 6 minutes). Pain intensity will be measured by a numerical rating scale (NRS) recorded every half hour up to 2 hours after initial opioid administration. Primary endpoints are rate of change in pain intensity from 30 minutes after initial administration of opioid to 2 hours as suggested by the results of the preliminary study and incidence of adverse events. PCA will also be compared to non-PCA opioid analgesia assessed at the end of the 2 hour study period by patient satisfaction with pain management; registered nurse (RN) assessment of time efficiency/ease of use and satisfaction with pain management; and physician satisfaction with pain management. Resource utilization and cost associated with implementation and use of PCA in the ED setting will be assessed by total Registered nurse (RN) time spent on pain management per patient; pharmacy preparation time per patient; material cost per patient and Registered Nurse and Physician training time necessary for PCA implementation. Significance: If PCA is demonstrated to be effective, safe, and associated with patient and provider acceptance and acceptable resource utilization, it has the potential to significantly improve ED pain management.

Conditions
Pain
Being tested
Patient controlled analgesia (PCA), Usual Care
Keywords
Pain, Emergency, Analgesia, ED patients, acute pain, IV opioid
Medical subject headings
Pain, Emergencies, Agnosia, Acute Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient controlled analgesia (PCA)Device

    Loading dose 0.1 mg/kg morphine and demand dose of 1 mg morphine available every 6 minutes

  • Usual CareOther

    Usual opioid analgesia determined by the provider

Study groups in NCT01775371
Study groupRoleWhat they receive
Patient Controlled AnalgesiaExperimentalPCA (loading dose 0.1 mg/kg morphine and demand dose of 1 mg morphine available every 6 minutes)
Receives: Device: Patient controlled analgesia (PCA)
Usual CareActive comparatorUsual opioid analgesia determined by the provider
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of Change in Pain Intensity Per Hour

    Rate of Change in Numerical Rating Scale (NRS) of Pain per hour where 0 indicates "no pain", 10 indicates "worst possible pain" between 30 minutes and 120 minutes post-baseline i.e. NRS at 30 minutes minus NRS at 120 minutes post-baseline.

    Measured: 1.5 hours

Secondary outcomes (2)
  1. Number of Participants With One or More Adverse Events

    Number of participants with one or more adverse events defined by: oxygen saturation measured by pulse oximetry < 92% for one minute or more, respiratory rate <10 breaths/min counted for 60 seconds, or systolic blood pressure < 90 mm Hg.

    Measured: 2 hours

  2. Patient Satisfaction With Pain Management

    Self report of satisfaction with treatment at120 minutes after baseline

    Measured: 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionFeb 2016
  4. Study completionFeb 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
636 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01775371
Sponsor's protocol ID
2012-485
Other IDs
R01NR013980
Status last verified
Nov 2020
First submitted
3 Oct 2012
Last updated
4 Dec 2020
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study of Pain, run by Albert Einstein College of Medicine at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 4 Dec 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of Change in Pain Intensity Per Hour (time frame: 1.5 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in